Fish oil
- Generic Name
- Fish oil
- Brand Names
- Omegaven
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- XGF7L72M0F
- Background
Fish oil is a component of SMOFLIPID, which was FDA approved in July 2016. It is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
...
- Indication
Under FDA approval, fish oil pharmaceuticals are typically products consisting of a combination of the omega-3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and are indicated primarily as an adjunct to diet to reduce triglyceride levels in adult patients with severe (>=500 mg/dL) hypertriglyceridemia .
...
- Associated Conditions
- -
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Parenteral Nutrition
Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
- Conditions
- Interventions
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 25871
- Registration Number
- NCT01351805
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury
- First Posted Date
- 2011-03-30
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Midwestern Regional Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01325584
- Locations
- 🇺🇸
Cancer Treatment Centers of America at Midwestern Regional Medical Center, Zion, Illinois, United States
Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
- Conditions
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- Children's Hospital of Philadelphia
- Registration Number
- NCT01297933
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 10
- Registration Number
- NCT01173159
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
- First Posted Date
- 2009-09-01
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 62
- Registration Number
- NCT00969332
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
- First Posted Date
- 2009-03-17
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT00862446
- Locations
- 🇺🇸
Monroe Carell Jr Children's Hospital at vanderbilt, Nashville, Tennessee, United States
Compassionate Use of Omegaven IV Fat Emulsion
- Conditions
- Interventions
- First Posted Date
- 2009-01-01
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Cindy Haller
- Target Recruit Count
- 15
- Registration Number
- NCT00816348
- Locations
- 🇺🇸
Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
🇺🇸Cohen Children's Medical Cenetr of New York at North Shore, Manhasset, New York, United States
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
- Conditions
- Interventions
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 293
- Registration Number
- NCT00738101
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
- Conditions
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Carsten Skarke, MD
- Target Recruit Count
- 40
- Registration Number
- NCT00682318
- Locations
- 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 190
- Registration Number
- NCT00552084
- Locations
- 🇺🇸
Vanderbilt Medical School, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.